Skip to main content

Arkadios Wealth Advisors

Position in CRSP — CRISPR Therapeutics AG

CIK 1800798 ATLANTA, GA

Position in CRSP

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$571,960
+$124,042 QoQ
Shares Held
10,487
+11.4% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#209
of 521 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRSP Over Time

Shares Held

Position Value (USD)

Derivatives in CRSP

reported options exposure · as of Jun 30, 2026
CallValue
$10,908
CallShares
200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Arkadios Wealth Advisors holds $12,683,379 across 13 Biotechnology names. CRSP ranks #7 (4.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 CRSP
CRISPR Therapeutics AG
This page
10,487 $571,960

All Filings in CRSP

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $571,960 10,487
2026-06-30 $10,908 200
2026-03-31 $447,918 9,416
2026-03-31 $9,514 200
2025-12-31 $493,826 9,417
2025-12-31 $10,488 200
2025-09-30 $671,949 10,368
2025-09-30 $12,962 200
2025-06-30 $516,313 10,615
2025-06-30 $43,776 900
2025-03-31 $382,428 11,238
2024-12-31 $478,656 12,161
2024-09-30 $530,639 11,295
2024-06-30 $581,741 10,771
2024-03-31 $740,694 10,867
2023-12-31 $690,165 11,025
2023-09-30 $511,091 11,260
2023-06-30 $624,838 11,130
2023-03-31 $528,648 11,688
2022-12-31 $476,905 11,732
2022-09-30 $851,771 13,034
2022-06-30 $805,202 13,250
2022-03-31 $830,070 13,224
2021-12-31 $971,499 12,820
2021-09-30 $19,028 170
2021-06-30 $27,521 170
2020-12-31 $5,205 34
2020-09-30 $1,672 20
2020-06-30 $1,469 20
2020-03-31 $848 20